Study of Hepatitis Eradication Receiving Protease Inhibitor Administration
NCT03886077
·
clinicaltrials.gov ↗
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Morality
Interventions
DRUG:
glecaprevir/pibrentasivir
Sponsor
Sentara Norfolk General Hospital